Overexpression of SIRT1 exhibits protective effects against the development of neurological symptoms in AD models, and thus, designing therapeutics based on SIRT1 activity might be useful to develop treatment methods for this disease (Lalla and Donmez 2013). The gene discussed is SIRT1; the disease is Alzheimer disease.